Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Po-Lan Su

Showing results (21-30 of 68) with videos related to

Pageof 7
Sort By:
JTO Clinical and Research Reports|September 30, 2021
Durable Response to Combined Dabrafenib and Trametinib in a Patient With BRAF K601E Mutation-Positive Lung Adenocarcinoma: A Case ReportPo-Lan Su, Chien-Yu Lin, Yi-Lin Chen, et al.
Plos One|February 16, 2018
The impact of EGFR mutations on the incidence and survival of stages I to III NSCLC patients with subsequent brain metastasisWei-Yuan Chang, Yi-Lin Wu, Po-Lan Su, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|February 11, 2020
Effects of a comprehensive physical therapy on moderate and severe obstructive sleep apnea- a preliminary randomized controlled trialHsin-Yu Lin, Chih-Ju Chang, Chan-Chi Chiang, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|March 29, 2022
Oropharyngeal Rehabilitation for Patients With Moderate to Severe Obstructive Sleep Apnea After Transoral Robotic SurgeryYi-Ju Lai, Po-Lan Su, Chung-Yi Li, et al.
Molecular Cancer|May 10, 2024
DLL3-guided therapies in small-cell lung cancer: from antibody-drug conjugate to precision immunotherapy and radioimmunotherapyPo-Lan Su, Karthik Chakravarthy, Naoki Furuya, et al.
JAMA Network Open|December 5, 2024
Cardiac Events and Survival in Patients With EGFR-Mutant Non-Small Cell Lung Cancer Treated With OsimertinibChien-Yu Lin, Wei-Ting Chang, Po-Lan Su, et al.
Scientific Reports|December 29, 2022
The surgical resection of the primary tumor increases survival in patients with EGFR-mutant advanced non-small cell lung cancer: a tertiary center cohort studyYing-Yuan Chen, Po-Lan Su, Wei-Li Huang, et al.
Medicine|August 16, 2019
Brain MRI imaging characteristics predict treatment response and outcome in patients with de novo brain metastasis of EGFR-mutated NSCLCChia-Ying Lin, Chao-Chun Chang, Po-Lan Su, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|April 26, 2022
Corrigendum to The occurrence of and risk factors for developing acute critical illness during quarantine as a response to the COVID-19 pandemic [Journal of the Formosan Medical Association, Volume 121 (January 2022) Pages 81-88)Chin-Shiang Tsai, Tang-Hsiu Huang, Po-Lan Su, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|February 8, 2021
The occurrence of and risk factors for developing acute critical illness during quarantine as a response to the COVID-19 pandemicChin-Shiang Tsai, Tang-Hsiu Huang, Po-Lan Su, et al.
Pageof 7

Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
JTO Clinical and Research Reports|September 30, 2021
Durable Response to Combined Dabrafenib and Trametinib in a Patient With BRAF K601E Mutation-Positive Lung Adenocarcinoma: A Case ReportPo-Lan Su, Chien-Yu Lin, Yi-Lin Chen, et al.
Plos One|February 16, 2018
The impact of EGFR mutations on the incidence and survival of stages I to III NSCLC patients with subsequent brain metastasisWei-Yuan Chang, Yi-Lin Wu, Po-Lan Su, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|February 11, 2020
Effects of a comprehensive physical therapy on moderate and severe obstructive sleep apnea- a preliminary randomized controlled trialHsin-Yu Lin, Chih-Ju Chang, Chan-Chi Chiang, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|March 29, 2022
Oropharyngeal Rehabilitation for Patients With Moderate to Severe Obstructive Sleep Apnea After Transoral Robotic SurgeryYi-Ju Lai, Po-Lan Su, Chung-Yi Li, et al.
Molecular Cancer|May 10, 2024
DLL3-guided therapies in small-cell lung cancer: from antibody-drug conjugate to precision immunotherapy and radioimmunotherapyPo-Lan Su, Karthik Chakravarthy, Naoki Furuya, et al.
JAMA Network Open|December 5, 2024
Cardiac Events and Survival in Patients With EGFR-Mutant Non-Small Cell Lung Cancer Treated With OsimertinibChien-Yu Lin, Wei-Ting Chang, Po-Lan Su, et al.
Scientific Reports|December 29, 2022
The surgical resection of the primary tumor increases survival in patients with EGFR-mutant advanced non-small cell lung cancer: a tertiary center cohort studyYing-Yuan Chen, Po-Lan Su, Wei-Li Huang, et al.
Medicine|August 16, 2019
Brain MRI imaging characteristics predict treatment response and outcome in patients with de novo brain metastasis of EGFR-mutated NSCLCChia-Ying Lin, Chao-Chun Chang, Po-Lan Su, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|April 26, 2022
Corrigendum to The occurrence of and risk factors for developing acute critical illness during quarantine as a response to the COVID-19 pandemic [Journal of the Formosan Medical Association, Volume 121 (January 2022) Pages 81-88)Chin-Shiang Tsai, Tang-Hsiu Huang, Po-Lan Su, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|February 8, 2021
The occurrence of and risk factors for developing acute critical illness during quarantine as a response to the COVID-19 pandemicChin-Shiang Tsai, Tang-Hsiu Huang, Po-Lan Su, et al.
Pageof 7